Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells.

[1]  S. Gygi,et al.  Host Resistance to Lung Infection Mediated by Major Vault Protein in Epithelial Cells , 2007, Science.

[2]  E. Kubo,et al.  Up-regulation of P-glycoprotein expression by osmotic stress in rat sugar cataract. , 2007, Experimental eye research.

[3]  T. Furukawa,et al.  Direct activation of the human major vault protein gene by DNA-damaging agents. , 2006, Oncology reports.

[4]  E. Wiemer,et al.  Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. , 2005, Cancer research.

[5]  D. Corey,et al.  Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. , 2005, Biochemistry.

[6]  M. Burg,et al.  Hypertonic stress response. , 2005, Mutation research.

[7]  T. Furukawa,et al.  Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. , 2004, Biochemical and biophysical research communications.

[8]  P. Sonneveld,et al.  Efflux Kinetics and Intracellular Distribution of Daunorubicin Are Not Affected by Major Vault Protein/Lung Resistance-Related Protein (Vault) Expression , 2004, Cancer Research.

[9]  E. Wiemer,et al.  The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling* , 2004, Journal of Biological Chemistry.

[10]  P. Sonneveld,et al.  Vaults: a ribonucleoprotein particle involved in drug resistance? , 2003, Oncogene.

[11]  K. Storey,et al.  Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress , 2003, Journal of Experimental Biology.

[12]  Rosamonde E Banks,et al.  Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma , 2003, Proteomics.

[13]  P. Hohenberger,et al.  Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Monti,et al.  Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  L. Rome,et al.  A very early induction of major vault protein accompanied by increased drug resistance in U‐937 cells , 2002, International journal of cancer.

[16]  P. Schlag,et al.  Hyperthermia-induced Nuclear Translocation of Transcription Factor YB-1 Leads to Enhanced Expression of Multidrug Resistance-related ABC Transporters* , 2001, The Journal of Biological Chemistry.

[17]  W. Walther,et al.  Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. , 2000, Biochemical and biophysical research communications.

[18]  E. Wiemer,et al.  Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer , 2000, Current opinion in oncology.

[19]  W. Berger,et al.  Expression of the major vault protein LRP in human non‐small‐cell lung cancer cells: Activation by short‐term exposure to antineoplastic drugs , 2000, International journal of cancer.

[20]  S. Takao,et al.  Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. , 1999, Journal of the National Cancer Institute.

[21]  J. Baak,et al.  Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis. , 1999, Journal of clinical pathology.

[22]  V. Kickhoefer,et al.  Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.

[23]  K. Kohno,et al.  Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene* , 1998, The Journal of Biological Chemistry.

[24]  R. Shoemaker,et al.  Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines , 1997, International journal of cancer.

[25]  R. Shoemaker,et al.  Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. , 1997, Journal of the National Cancer Institute.

[26]  S. Akiyama,et al.  Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. , 1997, Cancer letters.

[27]  R. Shoemaker,et al.  Overlapping phenotypes of multidrug resistance among panels of human cancer‐cell lines , 1996, International journal of cancer.

[28]  H. Clevers,et al.  The drug resistance-related protein LRP is the human major vault protein , 1995, Nature Medicine.

[29]  K. Kohno,et al.  Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. , 1994, Biochemical and biophysical research communications.

[30]  L. Schwartz,et al.  Programmed cell death, apoptosis and killer genes. , 1993, Immunology today.

[31]  M. Slovak,et al.  Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.

[32]  J. Kyhse-Andersen.  Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[34]  R. Pirker,et al.  Expression of the lung resistance protein in primary colorectal carcinomas. , 2001, Anticancer Research.

[35]  I. Roninson,et al.  Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. , 1998, Oncology research.